Skip to Main Content

Author Details

Gun Ho Jang
Ontario Institute for Cancer Research
2011
46
18
PMIDPaper TitleJournal TitlePublished Year
34583947Molecular characterisation of pancreatic ductal adenocarcinoma with <i>NTRK</i> fusions and review of the literature.J Clin Pathol2023
38028629Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC).Front Genet2023
37525960hENT1 as a Predictive Biomarker in PDAC-Response.Clin Cancer Res2023
37558751Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.NPJ Precis Oncol2023
37768107Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associated immune phenotypes in pancreatic cancer.J Pathol2023
36949200RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.Nature2023
36915452Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis.J Gastrointest Oncol2023
36927977Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma.Br J Cancer2023
35139353Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.Immunity2022
35547873Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.Front Oncol2022
35694787Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2022
36636049A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.J Gastrointest Oncol2022
36417526Widespread hypertranscription in aggressive human cancers.Sci Adv2022
36209277Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma.Nat Commun2022
36223343Mitochondrial fitness and cancer risk.PLoS One2022
36222851hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.Clin Cancer Res2022
32958704Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Clin Cancer Res2021
33524400Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.Gastroenterology2021
34644529Spatially confined sub-tumor microenvironments in pancreatic cancer.Cell2021
33962950NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4.Sci Adv2021
34294813The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer.Sci Rep2021
33051307Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics.Clin Cancer Res2021
32933947Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.Gut2021
31481506Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer.Clin Cancer Res2020
31964786A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.Clin Cancer Res2020
31932696Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32051610Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.Nat Genet2020
32891936Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy.EBioMedicine2020
32703770Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes.Cancer Discov2020
32816949A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination-deficient Pancreatic Cancer.Clin Cancer Res2020
32518206Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer Types.Mol Cancer Ther2020
32156747GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.Clin Cancer Res2020
30686769Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.Cancer Cell2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
31070984Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal Adenocarcinoma.JCO Clin Cancer Inform2019
31068372<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal Adenocarcinoma.Clin Cancer Res2019
30629588Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer.PLoS Comput Biol2019
29288237Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial.Clin Cancer Res2018
29853643Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.Cancer Discov2018
27768182Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.JAMA Oncol2017
27851734Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.Nature2017
27732578A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.Nature2016
25786235PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.Genome Biol2015
24192544WaveCNV: allele-specific copy number alterations in primary tumors and xenograft models from next-generation sequencing.Bioinformatics2014
24069028A method for calling copy number polymorphism using haplotypes.Front Genet2013
22174922A powerful test of parent-of-origin effects for quantitative traits using haplotypes.PLoS One2011
  • 1 - 46 of 46

Recommended Authors

Huwate Yeerna
Moores Cancer Center, University of California
Career Start Year 2015
Number of shared co-authors 0
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 13
Matthew H Bailey
Department of Biology at Brigham Young University
Career Start Year 2013
Number of shared co-authors 1
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Edik M Blais
University of Virginia
Career Start Year 2010
Number of shared co-authors 0
Daniel J Serie
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 1
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Career Start Year 2009
Number of shared co-authors 15
Jeran K Stratford
Research Triangle Institute (RTI)
Career Start Year 2009
Number of shared co-authors 0
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 7
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 4
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 20
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 4
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 2
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 12
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 4
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 6
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 7
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 7
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 27
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 16
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 2
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 10
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 22
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0

Collaborators

Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers 39
Robert E Denroche
Ontario Institute for Cancer Research
Co-authored papers 28
Faiyaz Notta
2Ontario Institute for Cancer Research
Co-authored papers 28
Julie M Wilson
Ontario Institute for Cancer Research
Co-authored papers 26
John M S Bartlett
University of Edinburgh
Co-authored papers 14
Dianne Chadwick
University Health Network
Co-authored papers 10
Steven J M Jones
University of British Columbia
Co-authored papers 9
Janessa Laskin
Co-authored papers 9
Marco A Marra
University of British Columbia
Co-authored papers 9
Ashton A Connor
Houston Methodist Hospital
Co-authored papers 8
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 7
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Michelle Chan-Seng-Yue
Princess Margaret Cancer Centre
Co-authored papers 6
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Andrew J Mungall
Co-authored papers 6
Paul M Krzyzanowski
Ontario Institute for Cancer Research
Co-authored papers 6
Richard A Moore
Co-authored papers 6
Steve E Kalloger
University of British Columbia
Co-authored papers 5
Mathieu Lemire
The Hospital for Sick Children
Co-authored papers 5
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers 5
Mehdi Masoomian
University Health Network
Co-authored papers 4
Danielle Pasternack
Nicklaus Children's Hospital
Co-authored papers 4
Gloria M Petersen
Mayo Clinic
Co-authored papers 4
Lee Timms
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 4
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 4
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Co-authored papers 4
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 3
Jessica K Miller
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 3
Timothy Beck
Human Longevity Inc.
Co-authored papers 3
Release 1.2